Basilia Zingarelli, Cincinnati Childrens Hospital Medical Center, United States Updates Copyright 2023 Mehdi, Pusapati, Anwar, Lohana, Kumar, Nandula, Nawaz, Tracey, Yang, LeRoith, Brownstein and Roth
There are two deadly obstacles that all people with type 1 diabetes constantly need to navigate around: The threats of severe low blood sugar (hypoglycemia) and diabetic ketoacidosis (DKA)
It wasnt until 2021 that Wegovy, another GLP-1 (glucagon-like peptide receptor agonist) was approved specifically for weight loss
What does a 6-week KLOW cycle mean
Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration
(BMI is an estimate of body fat based on height and weight.)The results indicate a shift in how weight-loss surgery candidates are viewing their treatment options, researchers said.Theres no one-size-fits-all approach to treating obesity, metabolic syndrome or diabetes and its related conditions, senior researcher Dr